Targacept Inc

Type: Company
Name: Targacept Inc
Nationality: United States
Web Address: http://www.targacept.com/
First reported May 21 2013 - Updated May 21 2013 - 1 reports

Buyers Accumulate Shares of Targacept, Up 1.5%

(Financial News Network On) Targacept (NASDAQ:TRGT) is one of today's biggest movers, up 1.5% to $5.62. The S&P is currently trading fractionally lower to 1,664 and the Dow Jones Industrial Average is trading fractionally higher to 15,337. Targacep ... [Published Individual.com - May 21 2013]
First reported May 20 2013 - Updated May 20 2013 - 2 reports

Targacept: The Winning Streak Continues...

Targacept (NASDAQ:TRGT) traded at a new 52-week high today of $5.60. So far today approximately 151,000 shares have been exchanged, as compared to an average 30-day volume of 180,000 shares.Targacept share prices have moved between a 52-week high of $5.60 ... [Published Financial News Network online - May 20 2013]
First reported May 20 2013 - Updated May 20 2013 - 1 reports

Shares of Targacept Rise to a New 52-Week High

Shares of Targacept (NASDAQ:TRGT) traded at a new 52-week high today of $5.55. So far today approximately 67,000 shares have been exchanged, as compared to an average 30-day volume of 180,000 shares.Targacept (NASDAQ:TRGT) is currently priced 0.7% above ... [Published Comtex SmarTrend - May 20 2013]
First reported May 20 2013 - Updated May 20 2013 - 1 reports

NM, TRGT, IEZ, UNTK, STP, FXE Are Seasonally Ripe To Go Down In the Next Five Weeks

BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Navios Maritime Holdings Inc (NYSE:NM), Targacept Inc (NASDAQ:TRGT), iShares Dow Jones US Oil Equipment & Svcs Index Fd (NYSE:IEZ), UniTek Global Services Inc (NASDAQ:UNTK), Southern ... [Published Individual.com - May 20 2013]
First reported May 18 2013 - Updated May 18 2013 - 1 reports

Shares of Targacept Rise Above Previous...

Shares of Targacept (NASDAQ:TRGT) traded today at $5.48, breaking its 52-week high. Approximately 649,000 shares have changed hands today, as compared to an average 30-day volume of 173,000 shares.Targacept Inc. is a a biopharmaceutical company engaged ... [Published Financial News Network online - May 18 2013]
First reported May 16 2013 - Updated May 16 2013 - 1 reports

Shares of Targacept Has Risen Above Previous 52-Week High

Targacept (NASDAQ:TRGT) traded at a new 52-week high today of $5.47. Approximately 73,000 shares have changed hands today, as compared to an average 30-day volume of 173,000 shares.There is potential upside of 1.7% for shares of Targacept based on a current ... [Published Comtex SmarTrend - May 16 2013]
First reported May 14 2013 - Updated May 15 2013 - 2 reports

Shares of Targacept Rise to a New 52-Week High

(Financial News NetwFork O) Shares of Targacept (NASDAQ:TRGT) traded at a new 52-week high today of $5.42. This new high was reached on approximately average trading volume as 207,000 shares traded hands, while the average 30-day volume is approximately ... [Published Individual.com - May 15 2013]
Entities: Targacept Inc, Stocks
First reported May 13 2013 - Updated May 13 2013 - 1 reports

Targacept Makes a Move: Up 1.6%

(Financial News Network On) Targacept (NASDAQ:TRGT) is one of today's notable stocks on the rise, up 1.6% to $5.19. The Dow is trading fractionally lower to 15,091 and the S&P is currently trading fractionally lower to 1,632. In the past 52 weeks, ... [Published Individual.com - May 13 2013]
First reported May 07 2013 - Updated May 08 2013 - 2 reports

Targacept's CEO Discusses Q1 2013 Results - Earnings Call Transcript

8:30 AM ETOperatorGood day, ladies and gentlemen, and welcome to the Q1 2013 Targacept Inc. Earnings Conference Call. My name is Sharlene and I’ll be your operator for today. At this time, all participants are in listen-only mode. We will conduct a question-and-answer ... [Published Seeking Alpha - May 08 2013]
First reported May 07 2013 - Updated May 07 2013 - 1 reports

Targacept, Inc. Reports First Quarter 2013 Financial Results

Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeuticsâ¢, today reported its financial results for the first quarter ended March 31, 2013. Targacept reported a net loss of $8.1 million for the first ... [Published BioSpace - May 07 2013]
Entities: Targacept Inc
First reported Apr 29 2013 - Updated Apr 30 2013 - 3 reports

Targacept completes recruitment of patients for Alzheimer's study [Winston-Salem Journal, N.C.]

April 30Targacept Inc. said Monday it has completed the recruitment of patients in the Phase 2b study of the drug compound TC-1734 as a treatment for mild-to-moderate Alzheimer's disease.The Winston-Salem biotechnology company expects to report top-line ... [Published Pharmacy Choice - Apr 30 2013]
First reported Apr 29 2013 - Updated Apr 29 2013 - 4 reports

Targacept Completes Recruitment In Phase 2b Trial Of TC-1734

Targacept, Inc. (TRGT: Quote) said Monday that it has completed recruitment of patients in the Phase 2b study of TC-1734 as a treatment for mild to moderate Alzheimer's disease.The company expects to report top-line results from the study in mid-2014 ... [Published RTTNews.com - Apr 29 2013]

Quotes

...By tracking the size and price of each montha'a "s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin."
...Stephen A Hill, Targacept's President and Chief Executive Officer. "Our thanks go to the patients, study sites and investigators who are collaborating with us in the effort to find a new medicine for this devastating disease."
...NTRODUCTIONS II-13Vertex Pharmaceuticals Receives USFDA Approval for KALYDECO(TM) II-13Glenmark Pharmaceuticals Discovers Novel Chemical Entity (NCE) "GRC 17536' Program II-13BioFocus DPI Rolls Out Novel Biologically- Targeted Libraries II-14"
Novel Treatment in SLE and Sjögren's Syndrome (10:15-11:45 AM, June 13th), "Effects of Blisibimod, a Subcutaneous Inhibitor of B-Cell Activating FactorFactor in Patients with SLE"

More Content

All (105) | News (67) | Reports (3) | Blogs (5) | Audio/Video (0) | Fact Sheets (0) | Press Releases (30)
sort by: Date | Relevance
World Ion Channel Modulating Drugs Market Canva... [Published Business Wire - May 24 2013]
COGSTATE LIMITED: Company Secretary Appointment [Published 4 Traders - May 24 2013]
Buyers Accumulate Shares of Targacept, Up 1.5% [Published Individual.com - May 21 2013]
Targacept: The Winning Streak Continues... [Published Financial News Network online - May 20 2013]
Targacept: The Winning Streak Continues (TRGT) [Published Individual.com - May 20 2013]
Shares of Targacept Rise to a New 52-Week High [Published Comtex SmarTrend - May 20 2013]
NM, TRGT, IEZ, UNTK, STP, FXE Are Seasonally Ri... [Published Individual.com - May 20 2013]
Shares of Targacept Rise Above Previous... [Published Financial News Network online - May 18 2013]
Recent 52-Week High Exceeded in Shares of Targa... [Published Comtex SmarTrend - May 17 2013]
Shares of Targacept Rise Above Previous 52-Week... [Published Individual.com - May 17 2013]
Targacept Inc. Files SEC Form 10-Q, Quarterly R... [Published NewsRX - May 17 2013]
Shares of Targacept Has Risen Above Previous 52... [Published Comtex SmarTrend - May 16 2013]
Shares of Targacept Rise to a New 52-Week High [Published Individual.com - May 15 2013]
Regional Report Triad May 2013 [Published Business North Carolina - May 15 2013]
Targacept Completes Recruitment in Phase 2b Tri... [Published Pharmacy Choice - May 15 2013]
Wide range of events on calendar [Published Yahoo! Canada - May 15 2013]
Recent 52-Week High Exceeded in Shares of Targa... [Published Individual.com - May 14 2013]
Targacept Makes a Move: Up 1.6% [Published Individual.com - May 13 2013]
Targacept: 52-Week High Recently Eclipsed (TRGT) [Published Individual.com - May 08 2013]
Targacept Completes Recruitment in Phase 2b Tri... [Published Equities.com - May 08 2013]
Global Ion Channel Modulators Industry [Published Zecco - May 08 2013]
Ion Channel Modulators - Global Strategic Busin... [Published Individual.com - May 08 2013]
BIOL Does A Deal, BLRX's Lined Up Events, CBST ... [Published RTTNews.com - May 08 2013]
Targacept's CEO Discusses Q1 2013 Results - Ear... [Published Zecco - May 08 2013]
Targacept's CEO Discusses Q1 2013 Results - Ear... [Published Seeking Alpha - May 08 2013]
Anthera Announces Additional Data from Phase 2b... [Published Equities.com - May 08 2013]
Anthera Announces Additional Data from Phase 2b... [Published BioMedReports - May 08 2013]
U.S./Canada daily earnings hits & misses May 7 ... [Published Globe and Mail - May 07 2013]
U.S./Canada daily earnings hits & misses May 7 ... [Published Globe and Mail - May 07 2013]
Codexis Ranks the Lowest in Terms of... [Published Financial News Network online - May 07 2013]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Up And Down The Ladder… Job Changes [Published Pharmalot - Mar 22 2013]
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them . Don’t be shy. Everyone wants ...
Williams Partners Part-Owner Buys More Than $14... [Published Wall St. Cheat Sheet - Mar 12 2013]
Williams Companies who is 10 percent Owner at Williams Partners L.P. ( NYSE:WPZ ), bought 3,000,000 shares at $47.66 per share for a total value of $142,980,000. The shares recently traded at $49.05, up $1.39, or 2.92% since the insider buy. Markets ...
Deals Of The Week Untangles The String of Pearls [Published The IN VIVO Blog - Mar 08 2013]
Speculation has abounded of late that Bristol-Myers Squibb is looking to do its largest acquisition ever – to add a crown jewel to its string-of-pearls. That’s the pharma’s loving nickname for an aggressive deal-making strategy in which it has lined ...
Pharmalot… Pharmalittle… Good Morning [Published Pharmalot - Mar 06 2013]
And so, the middle of the week has arrived. Climb every mountain, as they say. And to that, we add you should do so with a cup of stimulation in hand. So please join us as we quaff a few and, of course, get ready for another busy, busy day. After all, ...
Targacept Earnings: Everything You Must Know Now [Published Wall St. Cheat Sheet - Feb 13 2013]
Targacept, Inc. ( NASDAQ:TRGT ) had a loss and missed Wall Street’s expectations, BUT beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. Show your portfolio some love! Click here ...
1

Press Releases

sort by: Date | Relevance
World Ion Channel Modulating Drugs Market Canva... [Published Business Wire - May 24 2013]
Targacept Reports First Quarter 2013 Financial ... [Published Business Wire - May 07 2013]
Targacept Reports First Quarter 2013 Financial ... [Published Business Wire Health News - May 07 2013]
Targacept to Report First Quarter 2013 Financia... [Published Business Wire - Apr 30 2013]
Targacept to Report First Quarter 2013 Financia... [Published Business Wire Health News - Apr 30 2013]
1 2 3 4 5 6
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.